Contributions/Funding

Current:

  1. James and Ester King Biomedical Research Program: Copik (PI) 2019-2022  FL DOH Grant #9JK04                                                                Adoptive PM21-NK cells with PD-L1 blockade for treatment of lung cancer
  2. American Lung Association: PI: Parks GD, Copik AJ-(Co-PI)     07/2019-06/2020 ALA Grant# LCD-619391                                                        Novel Oncolytic Virus for Redirecting NK Cell Killing of Lung Cancer Cells
  3. Kiadis Pharma Copik, A (PI)                              11/01/2019-12/31/2012 Research Collaboration
  4. NIH 1R01AI136803-01 (PI: Jurgen Bullita UF, Alicja Copik co-I)
  5. Guillot-Henley Family AML Research Fund in loving memory of William L. Guillot Copik (PI) 2017-2020

Completed:

  1. Cyto-Sen Therapeutics, Inc. Copik, A (PI)   10/01/2018-12/15/2019 Research Collaboration          -TO3
  2. Cyto-Sen Therapeutics, Inc. Copik, A (PI)   06/01/2018-09/30/2018 Research Collaboration -TO2
  3. Cyto-Sen Therapeutics, Inc. Copik, A (PI)   11/01/2017-05/31/2018 Research Collaboration -TO1
  4. Cyto-Sen Therapeutics, Inc. Copik, A (PI)    10/01/2016-07/30/2017 Research Collaboration
  5. Breast Cancer Research Foundation Khaled, A(PI), Copik (co-PI)            03/01/2017-02/29/2018 0769010006 “Development of a Cytoskeletal- Disrupting Approach for the Treatment of Metastic Breast Cancer”
  6. UCF College of Medicine (COM) Copik, A (PI) 01/01/2016–11/30/2016 “Harnessing the power of NK cells and oncolytic viruses for novel treatment of ovarian cancer.”
  7. UCF College of Medicine (COM)Copik, A (PI) 01/01/2016–11/30/2016 “Toward development of NK cell therapy for HIV treatment.”
  8. Bankhead-Coley Biomedical Research Program: Copik (PI) 12/01/2013-12/01/2015 Grant#4BB06 “Establishing Particle-Activated Natural Killer cell therapy for treatment of AML in preclinical NSG mouse model”
  9. NIR Bankhead-Coley Biomedical Research Program: Copik (PI) 07/01/2012-12/31/2015 Grant #3BN02 “Generation of highly cytotoxic natural killer cells for cancer immunotherapy using novel microparticle approach”
  10. UCF College of Medicine (COM):Copik, A (PI) 11/1/2014-10/30/2015 Grant# A_2014_016 “Determining the mechanism(s) of plasma membrane particle stimulated natural killer cell expansion.”
  11. The Florida Hospital Gala Endowed Program for Oncology Research: Copik (PI) 2011-2013 “Developing Strategies for Immunotherapy using Natural Killer Cells”

For more information regarding donations, please see the following link:

https://med.ucf.edu/giving/development/